Saturday 31 October 2026
Export SBRA’s income statement to Excel — free account
Sabra Healthcare REIT, Inc.
SBRA Real Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024. In the quarter to June 2026, revenue grew 24.7%, EPS fell 135.7%, free cash flow fell 666.1% and total debt rose 5.91%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three.
19.74
0.13
+0.66%
Follow SBRA
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
29.14 | 32.07 | 283.80 | 0.00 | 0.00 | 25.93 | 62.76 | 10.84 | 13.70 | 26.76 |
Piotroski F-Score |
5 | 6 | 6 | 4 | 3 | 4 | 5 | 6 | 4 | 5 |
P/S ratio |
5.90 | 5.75 | 5.07 | 4.66 | 5.21 | 5.98 | 6.04 | 4.71 | 4.94 | 6.17 |
P/FCF ratio |
0.00 | 18.78 | 8.53 | 11.36 | 9.42 | 15.49 | 6.39 | 6.47 | 0.00 | 13.47 |
P/Operating CF |
52.28 | 50.57 | 41.67 | 43.09 | 30.29 | 40.07 | 41.83 | 37.89 | 24.43 | 38.17 |
P/B ratio |
1.62 | 1.48 | 1.17 | 0.95 | 0.88 | 1.05 | 1.15 | 0.90 | 0.59 | 1.58 |
Price to Tangible BV |
1.66 | 1.49 | 1.18 | 0.97 | 0.89 | 1.08 | 1.18 | 0.94 | 0.62 | 1.62 |
EV/Sales |
9.06 | 9.09 | 8.72 | 8.59 | 9.21 | 9.84 | 9.59 | 9.80 | 11.81 | 10.68 |
EV/EBITDA |
15.83 | 15.67 | 14.47 | 16.34 | 13.79 | 13.75 | 15.90 | 12.31 | 15.59 | 13.87 |
EV/Operating CF |
20.14 | 20.59 | 18.79 | 16.99 | 14.72 | 16.60 | 17.04 | 16.95 | 35.52 | 15.82 |
EV/FCF |
(122.74) | 29.69 | 14.68 | 20.93 | 16.65 | 25.46 | 10.16 | 13.46 | (34.25) | 23.32 |
Quick Ratio |
0.65 | 0.56 | 0.34 | 0.38 | 0.81 | 0.45 | 0.45 | 0.63 | 5.73 | 0.87 |
Current Ratio |
4.29 | 4.32 | 3.41 | 3.27 | 3.60 | 1.15 | 1.44 | 1.83 | 6.85 | 3.30 |
Net Debt/EBITDA |
5.53 | 5.76 | 6.07 | 7.47 | 5.99 | 5.38 | 5.89 | 6.39 | 9.07 | 5.86 |
Debt/Assets |
46.04% | 45.58% | 44.82% | 43.61% | 40.13% | 39.63% | 39.58% | 48.49% | 48.27% | 53.43% |
Debt/Equity |
0.90 | 0.88 | 0.86 | 0.82 | 0.71 | 0.70 | 0.69 | 0.99 | 0.99 | 1.19 |
Asset Turnover |
0.14 | 0.13 | 0.12 | 0.11 | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.11 |
Operating CF/Net income |
2.24 | 2.45 | 21.85 | (4.07) | (3.15) | 2.56 | 5.40 | 1.34 | 0.92 | 2.93 |
Capex/Depreciation |
(2.17) | (0.56) | 0.46 | (0.32) | (0.23) | (0.70) | 1.39 | 0.49 | (2.43) | (0.83) |
Interest Coverage |
2.28 | 2.07 | 1.83 | 1.33 | 2.04 | 2.51 | 1.72 | 2.07 | 2.21 | 2.04 |
| 5.59% | 4.57% | 0.47% | (2.41%) | (3.34%) | 4.01% | 2.05% | 8.05% | 6.65% | 5.80% | |
| 2.88% | 2.37% | 0.25% | (1.32%) | (1.90%) | 2.30% | 1.08% | 3.93% | 3.19% | 2.54% | |
ROIC |
3.04% | 2.93% | 2.50% | 1.60% | 2.22% | 2.75% | 2.33% | 2.97% | 1.96% | 3.77% |
Return on Tangible Assets |
3.06% | 2.58% | 0.28% | (1.47%) | (2.05%) | 2.61% | 1.28% | 4.54% | 2.25% | 2.86% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
6.93% | 7.12% | 7.33% | 6.33% | 6.09% | 5.47% | 4.67% | 5.95% | 7.94% | 6.78% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 |
Share Based Compensation of Revenue |
1.47% | 1.28% | 1.22% | 1.19% | 1.39% | 1.32% | 1.48% | 1.23% | 2.05% | 2.88% |
Graham Net Nets |
(0.47) | (0.51) | (0.65) | (0.76) | (0.70) | (0.67) | (0.61) | (1.10) | (1.43) | (0.70) |
Graham Number |
13.08 | 11.94 | 3.69 | 0.00 | 0.00 | 15.79 | 11.94 | 24.99 | 31.95 | 17.94 |
Earnings Yield |
3.43% | 3.12% | 0.35% | (2.70%) | (3.77%) | 3.86% | 1.59% | 9.22% | 7.30% | 3.74% |
Free Cash Flow Yield |
(1.25%) | 5.33% | 11.73% | 8.80% | 10.62% | 6.46% | 15.65% | 15.45% | (6.98%) | 7.43% |
Revenue per Share |
3.21 | 3.01 | 2.80 | 2.71 | 2.60 | 2.90 | 3.54 | 3.50 | 3.87 | 3.99 |
Operating CF per Share |
1.44 | 1.33 | 1.30 | 1.37 | 1.63 | 1.72 | 1.99 | 2.02 | 1.29 | 2.69 |
Capex per Share |
(1.68) | (0.41) | 0.36 | (0.26) | (0.19) | (0.60) | 1.35 | 0.52 | (2.62) | (0.87) |
Free Cash Flow per Share |
(0.24) | 0.92 | 1.66 | 1.11 | 1.44 | 1.12 | 3.34 | 2.55 | (1.33) | 1.83 |
Cash per Share |
0.32 | 0.28 | 0.20 | 0.23 | 0.53 | 0.32 | 0.26 | 0.33 | 5.56 | 0.53 |
Shareholders Equity per Share |
11.70 | 11.74 | 12.12 | 13.23 | 15.43 | 16.53 | 18.64 | 18.25 | 32.54 | 15.56 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
11.70 | 11.74 | 12.12 | 13.23 | 15.43 | 16.53 | 18.64 | 18.25 | 32.54 | 15.56 |
Free Cash Flow |
(57.20) | 215.40 | 384.81 | 256.36 | 315.01 | 231.30 | 624.94 | 453.94 | (140.83) | 119.35 |
Working Capital |
392.91 | 391.03 | 330.36 | 323.07 | 371.98 | 22.09 | 47.73 | 78.55 | 599.32 | 91.06 |
Capital Expenditures |
(405.82) | (95.14) | 84.24 | (59.37) | (41.38) | (123.55) | 252.46 | 93.35 | (276.62) | (56.58) |
Net Current Asset Value |
(2,157.37) | (2,053.47) | (2,116.27) | (2,225.95) | (2,072.20) | (2,408.01) | (2,424.32) | (3,237.18) | (2,893.19) | (1,119.61) |
EV/EBIT |
27.37 | 26.81 | 27.26 | 38.14 | 26.06 | 23.40 | 29.15 | 20.04 | 24.68 | 21.07 |
Capex to Sales |
0.52 | 0.14 | (0.13) | 0.10 | 0.07 | 0.21 | (0.38) | (0.15) | 0.68 | 0.22 |
Price to Operating Income |
17.82 | 16.95 | 15.83 | 20.70 | 14.74 | 14.23 | 18.34 | 9.64 | 10.32 | 12.16 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 |
Cash ROIC |
(1.05%) | 4.12% | 7.31% | 4.56% | 5.35% | 3.96% | 10.52% | 6.93% | (1.90%) | 5.28% |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
118.61 | 127.44 | 139.62 | 142.62 | 144.63 | 127.53 | 101.81 | 98.68 | 71.08 | 37.41 |
Average Assets |
5,398.54 | 5,344.91 | 5,566.91 | 5,857.19 | 5,976.16 | 6,027.45 | 6,367.30 | 6,848.79 | 4,649.10 | 2,367.38 |
Average Common Equity |
2,782.54 | 2,771.91 | 2,929.46 | 3,217.96 | 3,394.38 | 3,448.84 | 3,371.60 | 3,345.97 | 2,226.37 | 1,034.68 |
Columns are period end dates